Global Biodefense Market Research Report 2023
Global Biodefense Market Overview:
Global Biodefense Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Biodefense involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biodefense Market
The Biodefense Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Biodefense Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biodefense Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Biodefense Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biodefense market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Biodefense Market Segmentation
Global Biodefense Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Biodefense market has been segmented into:
Anthrax
Small Pox
Botulism
Radiation
Others
By Application, Biodefense market has been segmented into:
Medical hygiene
National defense
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biodefense market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biodefense market.
Top Key Players Covered in Biodefense market are:
PharmAthene
Inc.
Emergent BioSolutions
Inc.
Cleveland BioLabs
SIGA Technologies
DynPort Vaccine Company
LLC
Elusys Therapeutics
Inc.
Bavarian Nordic
Achaogen
Inc.
Ichor Medical Systems
Dynavax Technologies Corporation
Xoma Corporation
Objective to buy this Report:
1. Biodefense analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Biodefense market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Biodefense Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Biodefense involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biodefense Market
The Biodefense Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Biodefense Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biodefense Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Biodefense Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biodefense market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Biodefense Market Segmentation
Global Biodefense Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Biodefense market has been segmented into:
Anthrax
Small Pox
Botulism
Radiation
Others
By Application, Biodefense market has been segmented into:
Medical hygiene
National defense
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biodefense market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biodefense market.
Top Key Players Covered in Biodefense market are:
PharmAthene
Inc.
Emergent BioSolutions
Inc.
Cleveland BioLabs
SIGA Technologies
DynPort Vaccine Company
LLC
Elusys Therapeutics
Inc.
Bavarian Nordic
Achaogen
Inc.
Ichor Medical Systems
Dynavax Technologies Corporation
Xoma Corporation
Objective to buy this Report:
1. Biodefense analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Biodefense market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: BIODEFENSE MARKET BY TYPE
5.1 Biodefense Market Overview Snapshot and Growth Engine
5.2 Biodefense Market Overview
5.3 Anthrax
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Anthrax: Geographic Segmentation
5.4 Small Pox
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Small Pox: Geographic Segmentation
5.5 Botulism
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Botulism: Geographic Segmentation
5.6 Radiation
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Radiation: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2028F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
CHAPTER 6: BIODEFENSE MARKET BY APPLICATION
6.1 Biodefense Market Overview Snapshot and Growth Engine
6.2 Biodefense Market Overview
6.3 Medical hygiene
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Medical hygiene: Geographic Segmentation
6.4 National defense
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 National defense: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Biodefense Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Biodefense Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Biodefense Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PHARMATHENE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 INC.
7.4 EMERGENT BIOSOLUTIONS
7.5 INC.
7.6 CLEVELAND BIOLABS
7.7 SIGA TECHNOLOGIES
7.8 DYNPORT VACCINE COMPANY
7.9 LLC
7.10 ELUSYS THERAPEUTICS
7.11 INC.
7.12 BAVARIAN NORDIC
7.13 ACHAOGEN
7.14 INC.
7.15 ICHOR MEDICAL SYSTEMS
7.16 DYNAVAX TECHNOLOGIES CORPORATION
7.17 XOMA CORPORATION
CHAPTER 8: GLOBAL BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Anthrax
8.2.2 Small Pox
8.2.3 Botulism
8.2.4 Radiation
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Medical hygiene
8.3.2 National defense
CHAPTER 9: NORTH AMERICA BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Anthrax
9.4.2 Small Pox
9.4.3 Botulism
9.4.4 Radiation
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Medical hygiene
9.5.2 National defense
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Anthrax
10.4.2 Small Pox
10.4.3 Botulism
10.4.4 Radiation
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Medical hygiene
10.5.2 National defense
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Anthrax
11.4.2 Small Pox
11.4.3 Botulism
11.4.4 Radiation
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Medical hygiene
11.5.2 National defense
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Anthrax
12.4.2 Small Pox
12.4.3 Botulism
12.4.4 Radiation
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Medical hygiene
12.5.2 National defense
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Anthrax
13.4.2 Small Pox
13.4.3 Botulism
13.4.4 Radiation
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Medical hygiene
13.5.2 National defense
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: BIODEFENSE MARKET BY TYPE
5.1 Biodefense Market Overview Snapshot and Growth Engine
5.2 Biodefense Market Overview
5.3 Anthrax
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Anthrax: Geographic Segmentation
5.4 Small Pox
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Small Pox: Geographic Segmentation
5.5 Botulism
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Botulism: Geographic Segmentation
5.6 Radiation
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Radiation: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2028F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
CHAPTER 6: BIODEFENSE MARKET BY APPLICATION
6.1 Biodefense Market Overview Snapshot and Growth Engine
6.2 Biodefense Market Overview
6.3 Medical hygiene
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Medical hygiene: Geographic Segmentation
6.4 National defense
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 National defense: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Biodefense Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Biodefense Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Biodefense Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PHARMATHENE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 INC.
7.4 EMERGENT BIOSOLUTIONS
7.5 INC.
7.6 CLEVELAND BIOLABS
7.7 SIGA TECHNOLOGIES
7.8 DYNPORT VACCINE COMPANY
7.9 LLC
7.10 ELUSYS THERAPEUTICS
7.11 INC.
7.12 BAVARIAN NORDIC
7.13 ACHAOGEN
7.14 INC.
7.15 ICHOR MEDICAL SYSTEMS
7.16 DYNAVAX TECHNOLOGIES CORPORATION
7.17 XOMA CORPORATION
CHAPTER 8: GLOBAL BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Anthrax
8.2.2 Small Pox
8.2.3 Botulism
8.2.4 Radiation
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Medical hygiene
8.3.2 National defense
CHAPTER 9: NORTH AMERICA BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Anthrax
9.4.2 Small Pox
9.4.3 Botulism
9.4.4 Radiation
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Medical hygiene
9.5.2 National defense
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Anthrax
10.4.2 Small Pox
10.4.3 Botulism
10.4.4 Radiation
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Medical hygiene
10.5.2 National defense
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Anthrax
11.4.2 Small Pox
11.4.3 Botulism
11.4.4 Radiation
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Medical hygiene
11.5.2 National defense
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Anthrax
12.4.2 Small Pox
12.4.3 Botulism
12.4.4 Radiation
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Medical hygiene
12.5.2 National defense
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA BIODEFENSE MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Anthrax
13.4.2 Small Pox
13.4.3 Botulism
13.4.4 Radiation
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Medical hygiene
13.5.2 National defense
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIODEFENSE MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIODEFENSE MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIODEFENSE MARKET COMPETITIVE RIVALRY
TABLE 005. BIODEFENSE MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIODEFENSE MARKET THREAT OF SUBSTITUTES
TABLE 007. BIODEFENSE MARKET BY TYPE
TABLE 008. ANTHRAX MARKET OVERVIEW (2016-2028)
TABLE 009. SMALL POX MARKET OVERVIEW (2016-2028)
TABLE 010. BOTULISM MARKET OVERVIEW (2016-2028)
TABLE 011. RADIATION MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. BIODEFENSE MARKET BY APPLICATION
TABLE 014. MEDICAL HYGIENE MARKET OVERVIEW (2016-2028)
TABLE 015. NATIONAL DEFENSE MARKET OVERVIEW (2016-2028)
TABLE 016. NORTH AMERICA BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 017. NORTH AMERICA BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 018. N BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 019. EUROPE BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 020. EUROPE BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 021. BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 022. ASIA PACIFIC BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 023. ASIA PACIFIC BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 024. BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 027. BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 028. SOUTH AMERICA BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 029. SOUTH AMERICA BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 030. BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 031. PHARMATHENE: SNAPSHOT
TABLE 032. PHARMATHENE: BUSINESS PERFORMANCE
TABLE 033. PHARMATHENE: PRODUCT PORTFOLIO
TABLE 034. PHARMATHENE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 034. INC.: SNAPSHOT
TABLE 035. INC.: BUSINESS PERFORMANCE
TABLE 036. INC.: PRODUCT PORTFOLIO
TABLE 037. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. EMERGENT BIOSOLUTIONS: SNAPSHOT
TABLE 038. EMERGENT BIOSOLUTIONS: BUSINESS PERFORMANCE
TABLE 039. EMERGENT BIOSOLUTIONS: PRODUCT PORTFOLIO
TABLE 040. EMERGENT BIOSOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. INC.: SNAPSHOT
TABLE 041. INC.: BUSINESS PERFORMANCE
TABLE 042. INC.: PRODUCT PORTFOLIO
TABLE 043. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. CLEVELAND BIOLABS: SNAPSHOT
TABLE 044. CLEVELAND BIOLABS: BUSINESS PERFORMANCE
TABLE 045. CLEVELAND BIOLABS: PRODUCT PORTFOLIO
TABLE 046. CLEVELAND BIOLABS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. SIGA TECHNOLOGIES: SNAPSHOT
TABLE 047. SIGA TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 048. SIGA TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 049. SIGA TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. DYNPORT VACCINE COMPANY: SNAPSHOT
TABLE 050. DYNPORT VACCINE COMPANY: BUSINESS PERFORMANCE
TABLE 051. DYNPORT VACCINE COMPANY: PRODUCT PORTFOLIO
TABLE 052. DYNPORT VACCINE COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. LLC: SNAPSHOT
TABLE 053. LLC: BUSINESS PERFORMANCE
TABLE 054. LLC: PRODUCT PORTFOLIO
TABLE 055. LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. ELUSYS THERAPEUTICS: SNAPSHOT
TABLE 056. ELUSYS THERAPEUTICS: BUSINESS PERFORMANCE
TABLE 057. ELUSYS THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 058. ELUSYS THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. INC.: SNAPSHOT
TABLE 059. INC.: BUSINESS PERFORMANCE
TABLE 060. INC.: PRODUCT PORTFOLIO
TABLE 061. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. BAVARIAN NORDIC: SNAPSHOT
TABLE 062. BAVARIAN NORDIC: BUSINESS PERFORMANCE
TABLE 063. BAVARIAN NORDIC: PRODUCT PORTFOLIO
TABLE 064. BAVARIAN NORDIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. ACHAOGEN: SNAPSHOT
TABLE 065. ACHAOGEN: BUSINESS PERFORMANCE
TABLE 066. ACHAOGEN: PRODUCT PORTFOLIO
TABLE 067. ACHAOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. INC.: SNAPSHOT
TABLE 068. INC.: BUSINESS PERFORMANCE
TABLE 069. INC.: PRODUCT PORTFOLIO
TABLE 070. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. ICHOR MEDICAL SYSTEMS: SNAPSHOT
TABLE 071. ICHOR MEDICAL SYSTEMS: BUSINESS PERFORMANCE
TABLE 072. ICHOR MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 073. ICHOR MEDICAL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. DYNAVAX TECHNOLOGIES CORPORATION: SNAPSHOT
TABLE 074. DYNAVAX TECHNOLOGIES CORPORATION: BUSINESS PERFORMANCE
TABLE 075. DYNAVAX TECHNOLOGIES CORPORATION: PRODUCT PORTFOLIO
TABLE 076. DYNAVAX TECHNOLOGIES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. XOMA CORPORATION: SNAPSHOT
TABLE 077. XOMA CORPORATION: BUSINESS PERFORMANCE
TABLE 078. XOMA CORPORATION: PRODUCT PORTFOLIO
TABLE 079. XOMA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIODEFENSE MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIODEFENSE MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIODEFENSE MARKET COMPETITIVE RIVALRY
TABLE 005. BIODEFENSE MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIODEFENSE MARKET THREAT OF SUBSTITUTES
TABLE 007. BIODEFENSE MARKET BY TYPE
TABLE 008. ANTHRAX MARKET OVERVIEW (2016-2028)
TABLE 009. SMALL POX MARKET OVERVIEW (2016-2028)
TABLE 010. BOTULISM MARKET OVERVIEW (2016-2028)
TABLE 011. RADIATION MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. BIODEFENSE MARKET BY APPLICATION
TABLE 014. MEDICAL HYGIENE MARKET OVERVIEW (2016-2028)
TABLE 015. NATIONAL DEFENSE MARKET OVERVIEW (2016-2028)
TABLE 016. NORTH AMERICA BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 017. NORTH AMERICA BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 018. N BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 019. EUROPE BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 020. EUROPE BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 021. BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 022. ASIA PACIFIC BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 023. ASIA PACIFIC BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 024. BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 027. BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 028. SOUTH AMERICA BIODEFENSE MARKET, BY TYPE (2016-2028)
TABLE 029. SOUTH AMERICA BIODEFENSE MARKET, BY APPLICATION (2016-2028)
TABLE 030. BIODEFENSE MARKET, BY COUNTRY (2016-2028)
TABLE 031. PHARMATHENE: SNAPSHOT
TABLE 032. PHARMATHENE: BUSINESS PERFORMANCE
TABLE 033. PHARMATHENE: PRODUCT PORTFOLIO
TABLE 034. PHARMATHENE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 034. INC.: SNAPSHOT
TABLE 035. INC.: BUSINESS PERFORMANCE
TABLE 036. INC.: PRODUCT PORTFOLIO
TABLE 037. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. EMERGENT BIOSOLUTIONS: SNAPSHOT
TABLE 038. EMERGENT BIOSOLUTIONS: BUSINESS PERFORMANCE
TABLE 039. EMERGENT BIOSOLUTIONS: PRODUCT PORTFOLIO
TABLE 040. EMERGENT BIOSOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. INC.: SNAPSHOT
TABLE 041. INC.: BUSINESS PERFORMANCE
TABLE 042. INC.: PRODUCT PORTFOLIO
TABLE 043. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. CLEVELAND BIOLABS: SNAPSHOT
TABLE 044. CLEVELAND BIOLABS: BUSINESS PERFORMANCE
TABLE 045. CLEVELAND BIOLABS: PRODUCT PORTFOLIO
TABLE 046. CLEVELAND BIOLABS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. SIGA TECHNOLOGIES: SNAPSHOT
TABLE 047. SIGA TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 048. SIGA TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 049. SIGA TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. DYNPORT VACCINE COMPANY: SNAPSHOT
TABLE 050. DYNPORT VACCINE COMPANY: BUSINESS PERFORMANCE
TABLE 051. DYNPORT VACCINE COMPANY: PRODUCT PORTFOLIO
TABLE 052. DYNPORT VACCINE COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. LLC: SNAPSHOT
TABLE 053. LLC: BUSINESS PERFORMANCE
TABLE 054. LLC: PRODUCT PORTFOLIO
TABLE 055. LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. ELUSYS THERAPEUTICS: SNAPSHOT
TABLE 056. ELUSYS THERAPEUTICS: BUSINESS PERFORMANCE
TABLE 057. ELUSYS THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 058. ELUSYS THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. INC.: SNAPSHOT
TABLE 059. INC.: BUSINESS PERFORMANCE
TABLE 060. INC.: PRODUCT PORTFOLIO
TABLE 061. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. BAVARIAN NORDIC: SNAPSHOT
TABLE 062. BAVARIAN NORDIC: BUSINESS PERFORMANCE
TABLE 063. BAVARIAN NORDIC: PRODUCT PORTFOLIO
TABLE 064. BAVARIAN NORDIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. ACHAOGEN: SNAPSHOT
TABLE 065. ACHAOGEN: BUSINESS PERFORMANCE
TABLE 066. ACHAOGEN: PRODUCT PORTFOLIO
TABLE 067. ACHAOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. INC.: SNAPSHOT
TABLE 068. INC.: BUSINESS PERFORMANCE
TABLE 069. INC.: PRODUCT PORTFOLIO
TABLE 070. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. ICHOR MEDICAL SYSTEMS: SNAPSHOT
TABLE 071. ICHOR MEDICAL SYSTEMS: BUSINESS PERFORMANCE
TABLE 072. ICHOR MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 073. ICHOR MEDICAL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. DYNAVAX TECHNOLOGIES CORPORATION: SNAPSHOT
TABLE 074. DYNAVAX TECHNOLOGIES CORPORATION: BUSINESS PERFORMANCE
TABLE 075. DYNAVAX TECHNOLOGIES CORPORATION: PRODUCT PORTFOLIO
TABLE 076. DYNAVAX TECHNOLOGIES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. XOMA CORPORATION: SNAPSHOT
TABLE 077. XOMA CORPORATION: BUSINESS PERFORMANCE
TABLE 078. XOMA CORPORATION: PRODUCT PORTFOLIO
TABLE 079. XOMA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIODEFENSE MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIODEFENSE MARKET OVERVIEW BY TYPE
FIGURE 012. ANTHRAX MARKET OVERVIEW (2016-2028)
FIGURE 013. SMALL POX MARKET OVERVIEW (2016-2028)
FIGURE 014. BOTULISM MARKET OVERVIEW (2016-2028)
FIGURE 015. RADIATION MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. BIODEFENSE MARKET OVERVIEW BY APPLICATION
FIGURE 018. MEDICAL HYGIENE MARKET OVERVIEW (2016-2028)
FIGURE 019. NATIONAL DEFENSE MARKET OVERVIEW (2016-2028)
FIGURE 020. NORTH AMERICA BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. EUROPE BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. ASIA PACIFIC BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. MIDDLE EAST & AFRICA BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. SOUTH AMERICA BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIODEFENSE MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIODEFENSE MARKET OVERVIEW BY TYPE
FIGURE 012. ANTHRAX MARKET OVERVIEW (2016-2028)
FIGURE 013. SMALL POX MARKET OVERVIEW (2016-2028)
FIGURE 014. BOTULISM MARKET OVERVIEW (2016-2028)
FIGURE 015. RADIATION MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. BIODEFENSE MARKET OVERVIEW BY APPLICATION
FIGURE 018. MEDICAL HYGIENE MARKET OVERVIEW (2016-2028)
FIGURE 019. NATIONAL DEFENSE MARKET OVERVIEW (2016-2028)
FIGURE 020. NORTH AMERICA BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. EUROPE BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. ASIA PACIFIC BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. MIDDLE EAST & AFRICA BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. SOUTH AMERICA BIODEFENSE MARKET OVERVIEW BY COUNTRY (2016-2028)
